Literature DB >> 31999471

Tumor Necrosis Factor-Induced miR-146a Upregulation Promotes Human Lung Adenocarcinoma Metastasis by Targeting Merlin.

Nilda C Sánchez1,2, Elisa Medrano-Jiménez1, Diana Aguilar-León3, Leonor Pérez-Martínez1, Gustavo Pedraza-Alva1.   

Abstract

Inflammation plays a key role in carcinogenesis and metastasis. This process involves the inactivation of tumor suppressor molecules, yet the molecular mechanisms by which inflammation impairs tumor suppressors are not completely understood. In this study, we show that proinflammatory signals such as tumor necrosis factor (TNF) support lung cancer metastasis by reducing the levels of the tumor suppressor Merlin through regulation of miR-146a. Immunodeficient mice inoculated with A549 cells expressing high miR-146a levels and low Merlin protein levels exhibited reduced survival, which correlated with the number of metastatic nodes formed. Accordingly, restoring Merlin protein levels inhibited metastasis and increased survival of the mice. Consistent with these results, we found that elevated miR-146a expression levels correlated with low Merlin protein levels in human lung adenocarcinoma. Furthermore, human invasive and metastatic tumors showed higher TNF and miR-146a levels, but lower Merlin protein levels than noninvasive tumors. These findings indicate that upregulation of miR-146a by TNF in lung adenocarcinoma promotes Merlin protein inhibition and metastasis. Thus, we suggest that the ratio between miR-146a and Merlin protein levels could be a relevant molecular biomarker that can predict lung cancer progression and that the TNF/miR-146a/Merlin pathway is a promising new therapeutic target to inhibit lung adenocarcinoma progression.

Entities:  

Keywords:  Merlin; TNF; inflammation; lung cancer; metastasis; microRNAs

Year:  2020        PMID: 31999471     DOI: 10.1089/dna.2019.4620

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  2 in total

Review 1.  Clinico-Pathological Importance of miR-146a in Lung Cancer.

Authors:  Javaid Ahmad Wani; Sabhiya Majid; Andleeb Khan; Azher Arafah; Ajaz Ahmad; Basit Latief Jan; Naveed Nazir Shah; Mohsin Kazi; Muneeb U Rehman
Journal:  Diagnostics (Basel)       Date:  2021-02-10

2.  Inhibin βA is an independent prognostic factor that promotes invasion via Hippo signaling in non‑small cell lung cancer.

Authors:  Yijun Zhang; Shumei Yan; Yan Li; Jiangbo Zhang; Yuan Luo; Pengcheng Li; Yuanzhong Yang; Yong Li; Yuhua Huang; Enhua Wang
Journal:  Mol Med Rep       Date:  2021-09-10       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.